{"name":"Stereotaxis","slug":"stereotaxis","ticker":"STXS","exchange":"NYSE American","domain":"stereotaxis.com","description":"Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed to enhance the accessibility of Robotic Magnetic Navigation by reducing the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a Synchrony and SynX Solution offer integrated, real-time information solution to manage, control, record and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including MAGiC catheter, a robotically navigated magnetic ablation catheter designed to perf","hq":"St. Louis, MO","founded":0,"employees":"131","ceo":"David Fischel","sector":"Medical Devices / Robotic Surgery","stockPrice":1.96,"stockChange":0.11,"stockChangePercent":5.95,"marketCap":"$191M","metrics":{"revenue":31196000,"revenueGrowth":-15.8,"grossMargin":53.9,"rdSpend":9383000,"netIncome":-21643000,"cash":14616000,"dividendYield":0,"peRatio":-19.6,"fiscalYear":"FY2018"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-27","type":"earnings","headline":"Stereotaxis Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"Stereotaxis reported revenue of $14.1 million for the fourth quarter of 2023, a decrease of 13% compared to the same period in 2022.","drugName":"","sentiment":"neutral"},{"date":"2023-11-14","type":"deal","headline":"Stereotaxis Announces Collaboration with Medtronic to Develop Robotic Electrophysiology Platform","summary":"Stereotaxis has partnered with Medtronic to develop a robotic electrophysiology platform, which will integrate Stereotaxis' Niobe ES system with Medtronic's EP lab solutions.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxONnZKQ3JRdXFqSThlUlN2SDJIZnI4Y0tpM3NtVG5NLXowSWNBLUZfcmtrSEp2X3pjOHRjRHVIQTlpMUhTdTN1SE5pNktCQjA5MWlWTUpNZU8yRHZwMXpDdkpaaU9QdTR4NFNjamxZcWNCZDZIRmNmanRQV3lKVFRVOVJtZzF6MlpSRUdQN1hGb2lnQ2ZIbWx4cnVlVkRmR3N1YUhGaTNzcUhaS2VINHhlVzRvdzQ?oc=5","date":"2026-04-06","type":"regulatory","source":"Stock Titan","summary":"Stereotaxis gets FDA clearance for cath lab system, targets $3M - Stock Titan","headline":"Stereotaxis gets FDA clearance for cath lab system, targets $3M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNaWh3NnVVQmRJeXNVZGVsT1dWQlAxVDhUdUZQb3JpZlBZYTd6SkE2NnVEY1d2dkZzV1oxV3Jpa1ZyS2xDTU5ZM0ZSUFFvWmM4QURBV3NadF9ZeUFid2NZUVZaOUdQcWR6dGNkR3pkaE9lSkN5T2RRR3BQbTRibEdZT2VTNXFoUDhBMlBnWTFiTmE2c2JGNG1XOG9lU2tHVXJqb3Z1ZDlfLUZXTlVnRUlYUkJUd0k?oc=5","date":"2026-03-13","type":"pipeline","source":"Seeking Alpha","summary":"Stereotaxis: Medical Robotics Upside Offsets Cash Burn And Execution Risks (NYSE:STXS) - Seeking Alpha","headline":"Stereotaxis: Medical Robotics Upside Offsets Cash Burn And Execution Risks (NYSE:STXS)","sentiment":"neutral"},{"date":"2026-03-12","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-03-09","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNei1IbmRySTFYUzJBNFZCZ29qb2V4ZmZsV01LemJZNUpZUXVIbVVEdFhPOXRoeDBVU2QxdlZZZkVqUHpvdWNqUHJvbzlQT21heG1rdE1HUDlqRlFDZTRWOEVDdEhrNXJlUnppYWZYUU4tRGRVSzU1M2VnOFRLZlpDYlU2bFdNU2NUVGYzUFpELTI1NVVfRUs2SlNPdldDSlUtNkxZRm9XS0gyOVl0WW5WYUtOQnI?oc=5","date":"2026-02-09","type":"pipeline","source":"Stock Titan","summary":"First German heart center turns to robots to cut radiation - Stock Titan","headline":"First German heart center turns to robots to cut radiation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxOT1UtVEQ4WDdxSUQ0MXA0VnV1R2JSVm9GWVlXcUlNLVhfaTNOc0dzOTFkc0h0b1Fvc3ZfRFZ0WEo0NGRmSExjVnNhSWVRMlJybDlUb05rX21aZVVoNVJCVU1pcUZJRlQ0eE1ocTl4c2ZQalZzUGpSdm5JendrOV9RZWxMOXY3Tm50LTF4RDFoQmhtdFNiOEVmOGVyQjhkemZaRnl3Z3UwQ0lZMEtBaVE?oc=5","date":"2026-01-06","type":"regulatory","source":"Stock Titan","summary":"FDA approves MAGiC robotic heart catheter to treat complex arrhythmias - Stock Titan","headline":"FDA approves MAGiC robotic heart catheter to treat complex arrhythmias","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNcFJtMHltOFRTdmtzbmxPemtsUVdHaTItUVRYWG9tek9WYktiX3FxdHBRSl9GWllrUzJoMXhOY2FieEkwOU9pTXE4ZnY3cndRLVJCc0VBVDUwaUUtTW8wQ25malotSm8zdWh2ZElUV0NEcUo2VUFoOVdNY1plTHlfeFF3cTVqVFlpTHdHaWdrTzJMN3Vw?oc=5","date":"2025-12-15","type":"pipeline","source":"MarketBeat","summary":"3 Underrated Robotics Stocks Poised for Huge Gains - MarketBeat","headline":"3 Underrated Robotics Stocks Poised for Huge Gains","sentiment":"neutral"},{"date":"2025-11-12","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2025-11-12","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxNOEFqVnA5QzUyTHJSdFJ2UzRMa25McV9mTF9NMXVvSUFNVWFESFdpVlJuWEt3VlZjZmowMDYzNVRBMms1LW95SzlhTlZQOWpabmVmVWppWks5T2ljMGU0ejMtQXF4Ynd3S3hpbXJsMDQydnlYU2ZMOFBONEo0WGliMXRNclg2RDhaYy04VFVRa1I2TUROdk1IRHk0eUtSX0p1bnJBTnNaeWZ6bnpPNzBnakxJaXpuWmM?oc=5","date":"2025-11-10","type":"regulatory","source":"Stock Titan","summary":"Stereotaxis (NYSE: STXS) receives U.S. FDA 510(k) for GenesisX, 80% smaller cabinet - Stock Titan","headline":"Stereotaxis (NYSE: STXS) receives U.S. FDA 510(k) for GenesisX, 80% smaller cabinet","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxOdGNRTFFURElyajZKOXNlVkZMcmRCZTZabFZyd3BZSWtOUjRqOGNpVUV1WGtlM2xvSnNkTG9kcjVZX0t0emVwWUxoV1dGaDlYbmFWaGVWM0Z1MlhoV2hLOWhlSDloT216Uko3WWFvUGRnaWpyZWtBblpYbVVoOFpWN192MzhVemFqdzRnVFlqUzFEQ2Jmby1LZ29sdU1tb2ZGdW9aR3VtRHpyZG9LeXlEXzdnSEtaMEdWRjlaYnN3?oc=5","date":"2025-10-15","type":"pipeline","source":"Stock Titan","summary":"CE Mark & 510(k) Submission: Stereotaxis Launches Synchrony with 55” 4K Display and SynX Cloud - Stock Titan","headline":"CE Mark & 510(k) Submission: Stereotaxis Launches Synchrony with 55” 4K Display and SynX Cloud","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNQmZZaVJLUVptWW1hU20yQ1FmN2xrN3FvYmhCejU0LWhGQmFhWjdNUU8tc2RDeHhJZnRzbkZPMWtCcUViSDZLTmk3dWd6eDRYb0ZBeV9SRkdyOXc5U1Y1ZjhHWTV2Nm1FNWsyTm9kRVNRendJdVRmTTZodXc4UnJtTzFSa20yVGFQWGdiVXN5QkFuaEpJ?oc=5","date":"2025-09-22","type":"pipeline","source":"Seeking Alpha","summary":"Stereotaxis At Inflection Point: Why I Choose To HOLD (NYSE:STXS) - Seeking Alpha","headline":"Stereotaxis At Inflection Point: Why I Choose To HOLD (NYSE:STXS)","sentiment":"neutral"},{"date":"2025-08-29","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-08-13","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2025-08-07","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":2,"keyCompetitors":["Boston Scientific","Medtronic","Abbott Laboratories"],"therapeuticFocus":["Cardiac Arrhythmias","Electrophysiology"],"financials":{"source":"sec_edgar+yahoo","revenue":29346617,"revenuePeriod":"2018-12-31","revenueHistory":[{"value":29346617,"period":"2018-12-31"},{"value":31144100,"period":"2017-12-31"},{"value":31144100,"period":"2017-12-31"},{"value":32164116,"period":"2016-12-31"},{"value":32164116,"period":"2016-12-31"}],"grossProfit":17071000,"grossProfitHistory":[{"period":"2025-12-31","value":17071000},{"period":"2024-12-31","value":14594000},{"period":"2023-12-31","value":14860000},{"period":"2022-12-31","value":18470000}],"rdSpend":9383000,"rdSpendHistory":[{"period":"2025-12-31","value":9383000},{"period":"2024-12-31","value":9760000},{"period":"2023-12-31","value":10273000},{"period":"2022-12-31","value":10558000}],"sgaSpend":30292000,"operatingIncome":-22112000,"operatingIncomeHistory":[{"period":"2025-12-31","value":-22112000},{"period":"2024-12-31","value":-24739000},{"period":"2023-12-31","value":-21839000},{"period":"2022-12-31","value":-18776000}],"netIncome":-21643000,"netIncomeHistory":[{"period":"2025-12-31","value":-21643000},{"period":"2024-12-31","value":-24045000},{"period":"2023-12-31","value":-20713000},{"period":"2022-12-31","value":-18292000}],"eps":-0.25,"epsHistory":[{"period":"2025-12-31","value":-0.25},{"period":"2024-12-31","value":-0.3},{"period":"2023-12-31","value":-0.27},{"period":"2022-12-31","value":-0.26}],"cash":13421000,"cashHistory":[{"period":"2025-12-31","value":13421000},{"period":"2024-12-31","value":12217000},{"period":"2023-12-31","value":19818000},{"period":"2022-12-31","value":8586000}],"totalAssets":52251000,"totalLiabilities":33530000,"totalDebt":5436000,"equity":18721000,"operatingCashflow":-13685000,"operatingCashflowHistory":[{"period":"2025-12-31","value":-13685000},{"period":"2024-12-31","value":-8497000},{"period":"2023-12-31","value":-9139000},{"period":"2022-12-31","value":-8415000}],"capex":-93000,"capexHistory":[{"period":"2025-12-31","value":-93000},{"period":"2024-12-31","value":-34000},{"period":"2023-12-31","value":-366000},{"period":"2022-12-31","value":-2378000}],"freeCashflow":-13778000,"dividendsPaid":null,"buybacks":null,"employees":131,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":7266000,"ebit":-5649000,"ebitda":-5254000,"period":"2025-12-31","revenue":8642000,"epsBasic":-0.06,"netIncome":-5531000,"rdExpense":2710000,"epsDiluted":-0.06,"grossProfit":4327000,"operatingIncome":-5649000},{"sga":8112000,"ebit":-6557000,"ebitda":-6168000,"period":"2025-09-30","revenue":7464000,"epsBasic":-0.07,"netIncome":-6463000,"rdExpense":2546000,"epsDiluted":-0.07,"grossProfit":4101000,"operatingIncome":-6557000},{"sga":7271000,"ebit":-3977000,"ebitda":-3576000,"period":"2025-06-30","revenue":8798000,"epsBasic":-0.05,"netIncome":-3826000,"rdExpense":1777000,"epsDiluted":-0.05,"grossProfit":4579000,"operatingIncome":-3977000},{"sga":7643000,"ebit":-5929000,"ebitda":-5559000,"period":"2025-03-31","revenue":7472000,"epsBasic":-0.07,"netIncome":-5823000,"rdExpense":2350000,"epsDiluted":-0.07,"grossProfit":4064000,"operatingIncome":-5929000},{"sga":8053000,"ebit":-7627000,"ebitda":-7264000,"period":"2024-12-31","revenue":6340000,"epsBasic":-0.09,"netIncome":-7515000,"rdExpense":2790000,"epsDiluted":-0.09,"grossProfit":3216000,"operatingIncome":-7627000},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-09-30","revenue":null,"epsBasic":null,"netIncome":null,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":1.96,"previousClose":1.85,"fiftyTwoWeekHigh":3.59,"fiftyTwoWeekLow":1.74,"fiftyTwoWeekRange":"1.74 - 3.59","fiftyDayAverage":1.92,"twoHundredDayAverage":2.42,"beta":1.33,"enterpriseValue":176255376,"forwardPE":-19.6,"priceToBook":13.87,"priceToSales":6.11,"enterpriseToRevenue":5.65,"enterpriseToEbitda":-9.57,"pegRatio":0,"ebitda":-18419250,"ebitdaMargin":-59,"freeCashflow":0,"operatingCashflow":0,"totalDebt":5280000,"debtToEquity":26.9,"currentRatio":1.56,"returnOnAssets":-25.1,"returnOnEquity":-156.1,"analystRating":"1.5 - Strong Buy","recommendationKey":"strong_buy","numberOfAnalysts":4,"targetMeanPrice":4.25,"targetHighPrice":5,"targetLowPrice":4,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":15.4,"institutionHeldPercent":45.2,"sharesOutstanding":97487233,"floatShares":68823062,"sharesShort":3628158,"shortRatio":8.83,"shortPercentOfFloat":3.7,"epsTrailing":-0.24,"epsForward":-0.1,"revenuePerShare":0.33,"bookValue":0.14,"officers":[{"age":38,"name":"Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A.","title":"CEO & Chairman"},{"age":56,"name":"Ms. Kimberly R. Peery CPA","title":"Chief Financial Officer"},{"age":null,"name":"Mr. Keith  Galloway","title":"Vice President of Operations"},{"age":58,"name":"Ms. Patricia S. Williams Esq.","title":"General Counsel & Secretary"}],"industry":"Medical Instruments & Supplies","irWebsite":"","website":"https://www.stereotaxis.com","phone":"314 678 6100"}}